Volume 59, Issue 4, Pages (August 2008)

Slides:



Advertisements
Similar presentations
Teratoma Formation Leads to Failure of Treatment for Type I Diabetes Using Embryonic Stem Cell-Derived Insulin-Producing Cells  Takahisa Fujikawa, Seh-Hoon.
Advertisements

Fig. 1 Anti-inflammatory drug treatment reduces the number of reactive microglia in the hippocampus of APPV717I mice. APPV717I transgenic mice (10 months.
Cell Physiol Biochem 2016;38: DOI: /
Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models” by Karthikeyan Veeraraghavalu, Can Zhang, Sean.
Volume 3, Issue 4, Pages (October 2014)
Fig. 4. Proliferation and differentiation of the in vitro repetitive transcranial magnetic stimulation (rTMS) exposed neural stem and progenitor cells.
A B C D % positive cells 10 % Apoptotic nuclei 10 Figure S5 PM
Volume 9, Issue 5, Pages (November 2017)
Volume 11, Issue 2, Pages (August 2012)
Volume 59, Issue 3, Pages (August 2008)
Establishment of Endoderm Progenitors by SOX Transcription Factor Expression in Human Embryonic Stem Cells  Cheryle A. Séguin, Jonathan S. Draper, Andras.
Volume 12, Issue 2, Pages (February 2013)
Volume 5, Issue 6, Pages (December 2015)
Volume 8, Issue 1, Pages (January 2017)
Volume 10, Issue 3, Pages (March 2006)
Da Yong Lee, Scott M. Gianino, David H. Gutmann  Cancer Cell 
Volume 19, Issue 5, Pages (November 2016)
Volume 39, Issue 5, Pages (November 2013)
Volume 6, Issue 4, Pages (April 2016)
Volume 9, Issue 5, Pages (November 2017)
Volume 6, Issue 5, Pages (May 2016)
Volume 3, Issue 4, Pages (October 2014)
Volume 120, Issue 5, Pages (March 2005)
Volume 78, Issue 4, Pages (May 2013)
Volume 95, Issue 4, Pages e6 (August 2017)
Volume 85, Issue 3, Pages (February 2015)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 23, Issue 10, Pages e7 (June 2018)
Volume 1, Issue 2, Pages (August 2007)
Diazepam Binding Inhibitor Promotes Stem Cell Expansion Controlling Environment- Dependent Neurogenesis  Ionut Dumitru, Angela Neitz, Julieta Alfonso,
Molecular Therapy - Methods & Clinical Development
Volume 90, Issue 3, Pages (May 2016)
Volume 10, Issue 4, Pages (April 2018)
Isabelle Plaisance et al. BTS 2016;j.jacbts
Volume 4, Issue 6, Pages (June 2009)
Volume 9, Issue 6, Pages (December 2017)
Volume 70, Issue 5, Pages (June 2011)
Volume 7, Issue 1, Pages (January 2008)
Jin Wan, Rajesh Ramachandran, Daniel Goldman  Developmental Cell 
Volume 7, Issue 4, Pages (October 2010)
Volume 5, Issue 2, Pages (August 2015)
Volume 5, Issue 6, Pages (December 2009)
Alexandra Capela, Sally Temple  Neuron 
Volume 17, Issue 5, Pages (May 2009)
Volume 10, Issue 7, Pages (February 2015)
Volume 17, Issue 2, Pages (August 1996)
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Volume 12, Issue 4, Pages (April 2007)
Volume 20, Issue 4, Pages (October 2016)
Volume 9, Issue 5, Pages (November 2017)
EVA1A/TMEM166 Regulates Embryonic Neurogenesis by Autophagy
Volume 121, Issue 4, Pages (October 2001)
Kinesin-5 Is Essential for Growth-Cone Turning
Pranav Sharma, Hollis T. Cline  Neuron 
Volume 14, Issue 9, Pages (September 2007)
Volume 16, Issue 3, Pages (July 2016)
Volume 3, Issue 1, Pages (July 2014)
Volume 19, Issue 5, Pages (November 2016)
The Lymphocytic Choriomeningitis Virus Envelope Glycoprotein Targets Lentiviral Gene Transfer Vector to Neural Progenitors in the Murine Brain  Colleen.
Volume 6, Issue 5, Pages (May 2010)
Volume 90, Issue 3, Pages (May 2016)
MET/β-catenin complexes during synapse development.
Volume 5, Issue 2, Pages (August 2015)
Volume 49, Issue 4, Pages (February 2006)
Volume 120, Issue 5, Pages (March 2005)
Fang Du, Qing Yu, Allen Chen, Doris Chen, Shirley ShiDu Yan 
Deregulation of Dorsoventral Patterning by FGF Confers Trilineage Differentiation Capacity on CNS Stem Cells In Vitro  Limor Gabay, Sally Lowell, Lee.
Volume 11, Issue 4, Pages (October 2012)
Repulsive Guidance Molecule-a Is Involved in Th17-Cell-Induced Neurodegeneration in Autoimmune Encephalomyelitis  Shogo Tanabe, Toshihide Yamashita  Cell.
Volume 2, Issue 6, Pages (June 2014)
Presentation transcript:

Volume 59, Issue 4, Pages 568-580 (August 2008) Non-Cell-Autonomous Effects of Presenilin 1 Variants on Enrichment-Mediated Hippocampal Progenitor Cell Proliferation and Differentiation  Se Hoon Choi, Karthikeyan Veeraraghavalu, Orly Lazarov, Seoan Marler, Richard M. Ransohoff, Jan Marino Ramirez, Sangram S. Sisodia  Neuron  Volume 59, Issue 4, Pages 568-580 (August 2008) DOI: 10.1016/j.neuron.2008.07.033 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Expression of FAD-Linked PS1 Variants Impairs Enrichment-Induced Proliferation of Hippocampal Neural Progenitors (A–F) Photomicrographs of BrdU (green or yellow)+ cells in the DG of PS1hWT (A and D), PS1ΔE9 (B and E) and PS1M146L (C and F). SH, standard housing conditions (A, B, and C); EE, enriched conditions (D, E, and F). NeuN, red. Scale bar: 100 μm. (G) Quantification of BrdU+ cells (mean ± SEM; n = 10–15 per group). ∗p < 0.05. (H) Quantification of granule cell number. ∗p < 0.05. (I) Photomicrograph of primary neurospheres. Scale bar: 50 μm. (J) Image of nestin (green)+ neurosphere. Scale bar: 25 μm. (K) Nuclei were stained with DAPI (blue). (L) Percentage of multipotent neurospheres obtained in clonogenic neurosphere assay (mean ± SEM, n = 5 animals per group). ∗∗p < 0.01. Neuron 2008 59, 568-580DOI: (10.1016/j.neuron.2008.07.033) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 FAD-Linked PS1 Mutants Alter Differentiation Pattern of Neural Progenitors (A–E) Images of BrdU+ cells that are colabeled with either DCX (A), βIII-tubulin (B), NeuN (C), GFAP (D), or s100β (E). Scale bar: 50 μm (A, B, D, and E) or 100 μm (C). (F, H, J, L, and N) The fraction of BrdU+ cells that expressed DCX (F), βIII-tubulin (H), NeuN (J), GFAP (L), or s100β (N). (G, I, K, M, and O) The number of new DCX (G), βIII-tubulin (I), NeuN (K), GFAP (M), or s100β (O) cells. ∗p < 0.05; ∗∗p < 0.01. n = 8 per group. Neuron 2008 59, 568-580DOI: (10.1016/j.neuron.2008.07.033) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 FAD-Linked PS1 Mutant Mice Fail to Exhibit High Activity-Induced Increase in Microglial Cell Numbers (A–L) Images of microglia in DG of standard PS1hWT (A, B, and C), highly active PS1hWT (D, E, and F), highly active PS1M146L (G, H, and I), and highly active PS1hWT (high magnification; J, K, and L). Microglia are labeled with IB-4 (green; A, D, G, and J) and Iba1 (red; B, E, H, and K). Merged images are shown in (C), (F), (I), and (L). Scale bars: 100 μm in (A); 50 μm in (J). (M) Quantification of Iba1+ cells in standard or enriched PS1hWT and FAD-linked PS1 variants (mean ± SEM; n = 10–15 per group). (N) Quantification of Iba1+ cells in highly active or low active PS1hWT and FAD-linked PS1 variants. ∗p < 0.05. Neuron 2008 59, 568-580DOI: (10.1016/j.neuron.2008.07.033) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 Microglia Expressing FAD-Linked PS1 Variants Impair Proliferation of NPCs in In Vitro Coculture Assays (A) Proliferation achieved by NPCs, expressing PS1hWT, PS1ΔE9 or PS1M146L, grown in SFM supplemented with BrdU (mean ± SEM from a minimum of three experiments per group). (B–D) IB-4+ microglial cells (B, green) and nestin+ NPCs (C, red) under coculture conditions. The merged image is shown in (D). Fibrillar staining of the intermediate filament protein, Nestin, is evident on NPCs (arrowhead) but not on microglial cells (arrow). Scale bar: 10 μm. (E and F) Proliferation of PS1hWT NPCs when cocultured with AraC-treated resting (E) or IL-4-activated (F) microglia (MG) expressing PS1hWT, PS1ΔE9, or PS1M146L as measured by BrdU labeling. ∗∗ indicates significant difference from PS1hWT MG at p < 0.01 on day 3 or 6. (G–J) Confocal z series reconstructed image of cells stained with IB-4 (G), anti-nestin (H), anti-BrdU antibody (I), and DAPI (J), following 6 days under coculturing conditions. (K–N) Confocal images of a single z plane within nestin+ neural progenitor cluster (K, red, arrowhead) reveals several BrdU+ progenitors (K, cyan blue, enclosed within circle) and an IB-4+ MG (K, green, arrow). Insert shows the zoom-in area marked within dotted square (L). Scale bar: 50 μm. (M and N) Zoomed images of cells that are colabeled with BrdU/nestin (M) or BrdU/IB-4 (N). Scale bar: 10 μm. (O and P) Quantification of BrdU and nestin (O) or BrdU and IB-4 (P) colabeled cells in the coculture assay. The asterisk indicates significant difference from PS1hWT MG at ∗p < 0.05 and ∗∗p < 0.01. Neuron 2008 59, 568-580DOI: (10.1016/j.neuron.2008.07.033) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 5 Conditioned Media from Microglia Expressing FAD-Linked PS1 Variants Impair Proliferation of Neural Progenitors (A and B) Proliferation achieved by PS1hWT NPCs following treatment with conditioned media collected from resting (A) or IL-4-activated (B) microglia (MG) expressing mentioned PS1 transgenes, as measured by BrdU labeling. ∗∗ indicates significant difference from PS1hWT MG media at p < 0.01 on day 3 or 6. Neuron 2008 59, 568-580DOI: (10.1016/j.neuron.2008.07.033) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 6 Differentiation Pattern of Cultured NPCs Is Modulated by FAD-Linked PS1 Mutant Expressing Microglia (A) Progeny cell types generated by NPCs in the multipotency assay were quantified by sampling a minimum of 300 cells as marked by DAPI or propidium iodide+ nuclei (mean ± SEM of the results obtained from independent cultures established from six animals per group). (B) Fold changes in the number of βIII-tubulin+ neuronal or GFAP+ astrocyte progeny cell type derived from PS1hWT NPCs exposed to CM collected from resting or IL-4-activated MG, over differentiated PS1hWT NPC cultures in the absence of MG CM (mean ± SEM; n = 6). The asterisk indicates significant difference from PS1hWT MG CM at ∗p < 0.05 and ∗∗p < 0.01. Neuron 2008 59, 568-580DOI: (10.1016/j.neuron.2008.07.033) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 7 Quantitative Changes in Signaling Factors Secreted by PS1hWT versus FAD-Linked PS1 Variant Expressing Microglia (A) Images of biotin-label based protein antibody arrays probed with CM collected from resting or IL-4-activated microglia (MG). (B) Soluble factors whose levels were consistently altered (up or down “–”; mean ± SEM of fold changes observed across three experiments). – denotes no detectable change in mean signal intensity. Neuron 2008 59, 568-580DOI: (10.1016/j.neuron.2008.07.033) Copyright © 2008 Elsevier Inc. Terms and Conditions